Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert
December 20, 2022 03:01 ET
|
Mainz BioMed NV
Enrollment remains on track to complete in Q1 2023 with results in 1H 2023Potential to identify advanced adenomas, a type of pre-cancerous polyp often attributed to colorectal cancer (CRC) BERKELEY,...
Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study
December 06, 2022 03:01 ET
|
Mainz BioMed NV
ReconAAsense study examining the clinical performance of mRNA and DNA test combined with a fecal immunochemical test for early detection of advanced adenoma and colorectal cancer to enroll 15,000...
Mainz Biomed Appoints Amy Levin as Vice President of Regulatory Affairs to Oversee Global Regulatory Strategies
November 29, 2022 08:00 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Canon Medical Celebrates 30th Anniversary of Hybrid Angio-CT Technology with World’s First Deep Learning Spectral CT Reconstruction and HD 76 Technology Integration into Alphenix 4D CT System
November 28, 2022 09:00 ET
|
Canon Medical Systems USA
Tustin, California, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, Inc., a global leader in innovative diagnostic imaging technology, is proud to celebrate the 30th anniversary of...
Diagnostic Imaging Market Size is projected to reach USD 48 billion by 2029, with growth at a CAGR of 5.6% over the forecast period 2022-2029
November 23, 2022 10:00 ET
|
DataM Intelligence
ENTERPRISE, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Diagnostic Imaging Market Size Share Growth Insights: According to the research report published by DataM Intelligence, the global Diagnostic...
Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
November 22, 2022 08:00 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Point of Care Ultrasound Market to hit USD 5.5 Billion by 2030, says Global Market Insights Inc.
November 22, 2022 05:26 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The point of care ultrasound market value is set to reach USD 5.5 billion by 2030, according to a new research report by Global Market...
Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert
November 15, 2022 08:00 ET
|
Mainz BioMed NV
eAArly DETECT expected to complete enrollment in Q1 2023 with results in 1H 2023Enhances ColoFuture’s demographic profile and expedites data read-out timelinePotential to identify advanced adenomas, a...
[Latest] Global Respiratory Diagnostics Market Size/Share Worth USD 13.80 Billion by 2030 at an 8.5% CAGR: Custom Market Insights (Testing, Devices, Infection, Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth)
November 08, 2022 11:58 ET
|
Custom Market Insights
Sandy, Utah, USA, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Respiratory Diagnostic Market Size, Trends and Insights By Product and Services...
Mainz Biomed Provides Third Quarter 2022 Update
November 02, 2022 08:00 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...